Replies to post #1150 on Cytokinetics, Inc. (CYTK)

[Solantey]

Expecting a continued move higher into next Tuesday's first quarter earnings report and conference call.

Shorts need millions of shares here.

Potential $1 Billion in milestone payments + royalties from Amgen and Astellas on the company's other drugs.